Home » Stocks » IBIO

iBio, Inc. (IBIO)

Stock Price: $1.65 USD 0.00 (0.00%)
Updated May 11, 2021 4:00 PM EDT - Market closed
Market Cap 359.66M
Revenue (ttm) 2.33M
Net Income (ttm) -24.14M
Shares Out 216.01M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 11
Last Price $1.65
Previous Close $1.65
Change ($) 0.00
Change (%) 0.00%
Day's Open 1.55
Day's Range 1.55 - 1.69
Day's Volume 10,064,209
52-Week Range 1.01 - 7.45

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

These biotech penny stocks pushed up big today; but are they worth it? The post 4 Biotech Penny Stocks That You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other stocks mentioned: OBLN, PRPO, PTIX
1 day ago - PennyStocks

BRYAN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will repo...

1 day ago - GlobeNewsWire

Investors are excited about the company's new coronavirus vaccine program.

3 days ago - The Motley Fool

Ibio (IBIO) stock is soaring higher on Friday after announcing a next-generation vaccine program to treat the novel coronavirus. The post IBIO Stock: The Covid-19 Vaccine News Sending iBio Soaring Today...

4 days ago - InvestorPlace

iBio, Inc. (NYSE: IBIO) shares are trading higher after the company provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, I...

4 days ago - Benzinga

iBio Inc (NYSE: IBIO) has provided an update on its IBIO-201 program and reported its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of...

4 days ago - Benzinga

BRYAN, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today provided an update on its I...

5 days ago - GlobeNewsWire

A landmark legal settlement should bolster the biotech's growth prospects.

6 days ago - The Motley Fool

iBio Inc. (NYSE:IBIO) shares gapped higher Wednesday morning after the company announced it successfully resolved its lawsuit with Fraunhofer USA. The resolution confirms iBio's ownership of certain int...

6 days ago - Benzinga

Nemaura Medical Inc. (NASDAQ: NMRD), iBio, Inc. (NYSE: IBIO) and Cocrystal Pharma, Inc. (NASDAQ: COCP) are among the healthcare movers Wednesday. Nemaura Rallies On Receipt of Orders: Nemaura, a medtech...

6 days ago - Benzinga

Ibio (IBIO) stock is on the rise Wednesday after announcing an end to its legal battle with Fraunhofer USA and settlement agreement. The post IBIO Stock: The Big Lawsuit News That Has iBio Shares Rocket...

6 days ago - InvestorPlace

BRYAN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it has succe...

1 week ago - GlobeNewsWire

Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared fir...

Other stocks mentioned: MRNA, NVAX, OCGN, PPH, SRNE
1 month ago - InvestorPlace

Because of the pandemic, many so-called Covid stocks enjoyed outsized gains but investors might want to consider trimming their exposure. The post Take Your Profits!

Other stocks mentioned: APT, DOCU, MRNA, NVAX, PTON, SRNE
1 month ago - InvestorPlace

Don't bet on iBio for its coronavirus vaccine candidate. It's the company's FastPharming System that could move IBIO stock in the long term.

1 month ago - InvestorPlace

IBIO stock is not likely to move higher given its huge dilution. I think it is not worth more than 48 cents per share.

1 month ago - InvestorPlace

Low-priced biotechs have sold off recently, but there could still be potential in these picks. Here are eight penny stocks to consider.

Other stocks mentioned: AIM, ASXC, CLSN, JAGX, OVID, RIGL, VBIV
2 months ago - InvestorPlace

BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it will pa...

2 months ago - GlobeNewsWire

These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on...

Other stocks mentioned: BORR, EVFM, KSHB, OILFF, SB, TMBR
2 months ago - InvestorPlace

With iBio making key executive-level appointments and recording excellent fiscal stats, IBIO stock's value proposition is hard to ignore. The post Hold iBio Shares as Q2 Highlights Strong Product Catalo...

2 months ago - InvestorPlace

iBio (NYSE: IBIO) shares are trading lower Wednesday after the company reported second-quarter earnings results. iBio's main area of business is plant-based protein expression technologies for vaccines ...

Other stocks mentioned: BHC, DMAC, ONCY, OTLK
2 months ago - Benzinga

BRYAN, Tx., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial resu...

2 months ago - GlobeNewsWire

In the midst of an expensive market, traders are turning to penny stocks as a cheaper alternative. But avoid these seven risky penny names.

Other stocks mentioned: CTRM, GNUS, NAK, NAKD, SNDL, UXIN
2 months ago - InvestorPlace

BRYAN, Texas, Feb. 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will rep...

3 months ago - GlobeNewsWire

Ibio (IBIO) stock is on the rise Thursday despite a lack of news coming out today that would result in the movement today. The post IBIO Stock: 5 Things for Investors to Know About iBio Today as Shares ...

3 months ago - InvestorPlace

If January is a sign of things to come for 2021, traders and investors are going to make a lot of money this year. 4 penny stocks on the move are Anavex Life Sciences (NASDAQ: AVXL), iBio Inc (NYSEMKT: ...

3 months ago - OTC PR Wire

We may be seeing some sector rotation, and many companies that have made big moves in recent weeks have stocks under $10. The post 7 Stocks Under $10 to Buy for February  appeared first on InvestorPlace.

Other stocks mentioned: CRNT, FINV, HIMX, KOPN, RBBN, STON
3 months ago - InvestorPlace

One analyst says investors are underappreciating the biotech's growth prospects.

3 months ago - The Motley Fool

Shares of IBIO stock are taking off on Friday after an analyst from Cantor Fitzgerald initiated an Overweight rating and $3 price target. The post IBIO Stock Alert: Analyst Call Sends Shares of Pharma i...

3 months ago - InvestorPlace

Innovation paid off big for investors.

Other stocks mentioned: AQB, CTIC, ALPN
4 months ago - The Motley Fool

Obviously, we'll never forget this tumultuous year. During a calendar full of pandemic panic, economic crisis and social unrest, here are my best calls (and worst calls) of 2020.

Other stocks mentioned: BGFV, BYND, CWH, F, GME, MMEDF, NKLA
4 months ago - InvestorPlace

BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the appointment ...

4 months ago - GlobeNewsWire

It's the time to clean house and make portfolio space for stronger investment opportunities during 2021. Here are 7 stocks to sell.

Other stocks mentioned: HOG, INTC, WFC, HTZGQ, LKNCY, SOLO
4 months ago - InvestorPlace

Value stocks are surging lately. That's caused many penny stocks to roar back to life.

Other stocks mentioned: HOFV, NAK, SPG, WPG, WTER, CHK
4 months ago - InvestorPlace

BRYAN, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the closing of i...

5 months ago - GlobeNewsWire

IBIO stock remains volatile as the company continues its focus on a breakthrough product to combat the coronavirus pandemic. The post Be Wary as iBio Seeks a Place in the Vaccine Game appeared first on ...

5 months ago - InvestorPlace

This can happen when a company holds out its hand for a big chunk of fresh capital.

Other stocks mentioned: ARCT, MRNS
5 months ago - The Motley Fool

iBio (NYSE: IBIO) shares are trading lower on Tuesday after the company announced a common stock offering. iBio's main area of business is plant-based protein expression technologies for vaccines and th...

Other stocks mentioned: CMD, STRO
5 months ago - Benzinga

Investors bought the Covid-19 hype in IBIO stock. With little progress made, however, reality is setting in, which means the fade should continue.

5 months ago - InvestorPlace

The IBIO stock price is down, but that doesn't mean the company's in trouble. In fact, the data shows that iBio's fiscal health is improving.

5 months ago - InvestorPlace

BRYAN, Texas, Dec. 08, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the pricing of i...

5 months ago - GlobeNewsWire

While its shot at pioneering a novel coronavirus vaccine has passed, iBio and its IBIO stock could benefit from other medical breakthroughs. The post Why iBio Remains Worth a Look In a Post-Pandemic Lan...

5 months ago - InvestorPlace

BRYAN, Texas, Dec. 07, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced an underwritten ...

5 months ago - GlobeNewsWire

Biotech innovator IBIO stock has been tossed around based on iBio's COVID-19 vaccine progress, but its FastPharma tech is the long-term play. The post Biotech Innovator IBIO Is Down, but Not Out for the...

5 months ago - InvestorPlace

Ibio (IBIO) is seeing shares of IBIO stock soar higher on Wednesday following news of a contract for the biotech company. The post iBio News: Why IBIO Stock Is Soaring 16% Today appeared first on Invest...

5 months ago - InvestorPlace

BRYAN, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract development and manufacturing organization (“CDMO”), today a...

5 months ago - GlobeNewsWire

iBio has a long-standing relationship with the United States defense industry. But that hasn't enough to give IBIO stock a leg up in the Covid-19 race.

5 months ago - InvestorPlace

Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of ...

5 months ago - Insider Monkey

One of the more intriguing high-risk, high-reward ideas in the Covid-19 space, IBIO stock had an opportunity to distinguish itself. But with the vaccine race heating up, the dangers outweigh the possibi...

5 months ago - InvestorPlace

- Methods for Production in iBio's FastPharming® System Foundational to Antifibrotic Development Program - - Methods for Production in iBio's FastPharming® System Foundational to Antifibrotic Developmen...

5 months ago - GlobeNewsWire

About IBIO

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and related conditions. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavir... [Read more...]

Industry
Biotechnology
Stock Exchange
NYSEAMERICAN
Ticker Symbol
IBIO
Full Company Profile

Financial Performance

In 2020, iBio, Inc.'s revenue was $1.64 million, a decrease of -18.83% compared to the previous year's $2.02 million. Losses were -$16.44 million, -6.56% less than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for iBio, Inc. stock is "Strong Buy" and the 12-month stock price forecast is 2.50.

Price Target
$2.50
Analyst Consensus: Strong Buy